← FDA Drug Approvals (Drugs@FDA)

TAUKLARIFY

NDA · New Drug Application · Sponsor: CERVEAU LANTHEUS · Approved 2026-08-13

Drug application

FDA Application #

NDA220496

Application type

New Drug Application

Brand name

TAUKLARIFY

Generic name

Florquinitau F-18

Active ingredients

FLORQUINITAU F-18

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CERVEAU LANTHEUS

First approval

2026-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown